A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Overview of attention for article published in BMC Cancer, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

STABLE AND POTENT ANTI-ANGIOGENIC SCFV FRAGMENTS AND USES AS VEGF ANTAGONIST THEREOF

Application WO-2024058730-A1

World Intellectual Property Organisation (WIPO)

AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF

Application WO-2020160133-A1

World Intellectual Property Organisation (WIPO)

CANCER TREATMENT COMPOSITION FOR INHIBITING TUMOR ANGIOGENESIS, CONTAINING VEGF DEEP…

Application EP-3486254-A4

European Patent Office

FUSION PROTEIN TO BIND VEGF

Application EP-3239172-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.